Yarrow Bioscience (YARW) Other Accumulated Expenses (2017 - 2025)

Yarrow Bioscience (YARW) has 7 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2025.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $1.3 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.3 million (changed N/A YoY) and the FY2024 annual result came in at $1.3 million, changed N/A from the prior year.
• Other Accumulated Expenses held at $1.3 million in Q1 2025, from $1.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.3 million in Q2 2024 to a low of $104000.0 in Q1 2021.
• A 3-year average of $794857.1 and a median of $1.3 million in 2024 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 126.09% in 2021, down 72.77% in 2021.
• Tracing YARW's Other Accumulated Expenses over 3 years: stood at $104000.0 in 2021, then soared by 1162.5% to $1.3 million in 2024, then changed by 0.0% to $1.3 million in 2025.
• The last three Other Accumulated Expenses figures came in at $1.3 million (Q1 2025), $1.3 million (Q4 2024), and $1.3 million (Q3 2024), per Business Quant data.